By: Daniel Trecroci
On March 13, 2006, Abbott Diabetes Care of Alameda, California, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its FreeStyle Freedom blood glucose-monitoring system for consumer use.
According to Abbott, FreeStyle Freedom measures glucose levels using 0.3 microliters of blood—“the smallest sample size required of any blood glucose-monitoring product on the market.” FreeStyle Freedom also provides results in five seconds and features a large, high-contrast display, making it easy to read and easy to hold.
For more information, log on to www.abbott.com.
Source: Abbott Diabetes Care